Good et al. reported that following intravitreal anti-VEGF injection, patients with glaucoma have a higher incidence of elevated intraocular pressure and the pressure elevation sustained for longer period of time than patients without glaucoma [14]. This evidence concerns the gene VEGFA and glaucoma.